Iclusig
- Product NDC
- 63020-534
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ponatinib hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Application
- NDA203469
- Marketing category
- NDA
- Substance
- PONATINIB HYDROCHLORIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 63020-534-30 | 30 TABLET, FILM COATED in 1 BOTTLE (63020-534-30) | 2012-12-14 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Iclusig | Takeda Pharmaceuticals America, Inc. | Catalent Greenville, Inc. | Patheon Inc. | Takeda Ireland Limited | Almac Sciences (Ireland) Limited | 2026-04-29 | HUMAN PRESCRIPTION DRUG LABEL | 19 |
| Iclusig | Takeda Pharmaceuticals America, Inc. | Ash Stevens LLC | Catalent Micron Technologies, Inc. | Catalent Pharma Solutions, LLC | Sharp Packaging Services, LLC | Patheon Inc. | Takeda Ireland Limited | Almac Sciences (Ireland) Limited | 2024-12-19 | HUMAN PRESCRIPTION DRUG LABEL | 17 |